ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $116 | -4.1% | 44,300 | +31.5% | 0.00% | – |
Q2 2023 | $121 | +365.4% | 33,700 | +183.2% | 0.00% | – |
Q1 2023 | $26 | -100.0% | 11,900 | -96.7% | 0.00% | -100.0% |
Q2 2022 | $1,647,000 | -43.2% | 359,697 | +77.0% | 0.00% | -50.0% |
Q4 2021 | $2,902,000 | +83.8% | 203,200 | -45.4% | 0.00% | +100.0% |
Q4 2020 | $1,579,000 | +29.1% | 372,415 | -20.5% | 0.00% | +100.0% |
Q3 2020 | $1,223,000 | +54.4% | 468,615 | +108.9% | 0.00% | 0.0% |
Q2 2020 | $792,000 | +38.2% | 224,315 | +19.1% | 0.00% | 0.0% |
Q1 2020 | $573,000 | -51.2% | 188,415 | -17.3% | 0.00% | 0.0% |
Q4 2019 | $1,173,000 | +73.5% | 227,725 | +7.5% | 0.00% | 0.0% |
Q3 2019 | $676,000 | +19.0% | 211,925 | +34.0% | 0.00% | 0.0% |
Q2 2019 | $568,000 | +48.7% | 158,098 | +50.5% | 0.00% | – |
Q1 2019 | $382,000 | +117.0% | 105,055 | +79.5% | 0.00% | – |
Q4 2018 | $176,000 | -11.6% | 58,528 | +43.3% | 0.00% | – |
Q3 2018 | $199,000 | -76.6% | 40,845 | -66.8% | 0.00% | – |
Q2 2018 | $849,000 | +87.0% | 122,900 | +76.1% | 0.00% | – |
Q1 2018 | $454,000 | -46.1% | 69,800 | -25.3% | 0.00% | -100.0% |
Q4 2017 | $842,000 | +2.2% | 93,500 | +12.7% | 0.00% | 0.0% |
Q3 2017 | $824,000 | +322.6% | 83,000 | +230.7% | 0.00% | – |
Q2 2017 | $195,000 | – | 25,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 781,292 | $2,039,172 | 1.87% |
GSA CAPITAL PARTNERS LLP | 88,923 | $232 | 0.02% |
Glass Jacobson Investment Advisors llc | 12,255 | $31,986 | 0.02% |
Rathbones Group PLC | 289,803 | $756,386 | 0.01% |
N.E.W. Advisory Services LLC | 12,960 | $33,826 | 0.01% |
Virtu Financial LLC | 17,388 | $45 | 0.00% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $14,687 | 0.00% |
ALGERT GLOBAL LLC | 14,680 | $38 | 0.00% |
Close Asset Management Ltd | 11,400 | $30 | 0.00% |
Altshuler Shaham Ltd | 12,847 | $33,408 | 0.00% |